|
Integrated
pharmaceuticals, Inc. announces today acceptance of Kosher
Certification for all the products it manufactures
May
18, 2005
Integrated
Pharmaceuticals, Inc. Fitchburg, MA (OTC: PK: INTP) announced
today that, after successful completion of inspection of its
production facility, the company received the Kosher Certification
from the Orthodox Union (OU) for all of its products. The
company has recently added five products to its portfolio,
some of which are used primarily in food industries. The company
will be able to serve more customers with its OU certification.
Dr.
Chinmay Chatterjee, Ph.D., President and CEO of the company
said that "although IntePharm's all the products meet
and often exceeds US Pharmacopoeia standards, having been
certified by the Orthodox Union to sell as Kosher certified
product increases the company's market opportunities."
In
another note, Dr. Chatterjee mentioned that the company also
filed an amended Form 10-SB last week for SEC's review. The
new filing includes audited financial statements for 2004.
About the Company
IntePharm
is an emerging producer of pharmaceuticals, specialty compounds
and chemicals for the pharmaceutical, nutraceutical and food
industries. In addition to making products, IntePharm discovers
and develops more efficient and cost-effective manufacturing
processes. These processes are developed using a comprehensive
technology platform that combines metabolic engineering, cellular
genetics, advanced bioprocess engineering, and computer simulation
science. The company owns several pending patent applications
for new products and technologies related to the food and
nutritional products markets.
For
further information please contact Dr. Chinmay Chatterjee,
Integrated Pharmaceuticals, Inc. (IntePharm), at (978) 696-0020,
or visit http://www.intepharm.com.
Forward-Looking
Statements
Certain
statements contained in this press release that are not historical
facts constitute "Forward-Looking Statements" within
the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements, in general, predict,
indicate or imply future results, performance or achievements
and generally use words so indicative. Such forward-looking
statements involve known and unknown risks, uncertainties
and other factors that may cause the actual results or performance
of the Company and its business to be materially different
from that expressed or implied by such forward-looking statements.
Included in those factors are the following: our dependence
on a limited number of potential customers; limited managerial
experience of our executives; possible needs for additional
capital; possible delays in product development and delivery
schedules; deferred or lost sales because of the complex sales
process prevalent in the industries that we seek to serve;
increased competitive pressure; and rapid technological changes.
Forward-looking statements by their very nature are uncertain.
There can be no guarantee that any forward-looking statement
will be fulfilled. The Company assumes no obligation to update
forward-looking statements to reflect actual results or changes
in or additions to the factors affecting such forward-looking
statements.
SOURCE Integrated Pharmaceuticals, Inc.
Web Site: http://www.intepharm.com
Copyright © 1996-2004 PR Newswire Association
LLC. All Rights Reserved. A United Business Media company.
|
